{
    "2020-08-07": [
        [
            {
                "time": "",
                "original_text": "下周37股分红实施，3倍疫苗股藏其中",
                "features": {
                    "keywords": [
                        "分红",
                        "疫苗"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创新药盘点系列报告(14)：新冠疫苗和抗体：时间就是生命 效率就是金钱",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "抗体",
                        "效率"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：增长依赖代理产品 上半年净利润约15亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "代理产品",
                        "净利润"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "对话基金经理系列 | 前海联合林材：优选景气行业，精选具备核心竞争力的优质股",
                "features": {
                    "keywords": [
                        "基金经理",
                        "景气行业",
                        "核心竞争力"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物自研和代理疫苗销售双增 上半年盈利15亿投入1.4亿研发",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "自研",
                        "代理疫苗",
                        "盈利",
                        "研发投入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大数据揭秘：中美十倍股拥有四大共性",
                "features": {
                    "keywords": [
                        "大数据",
                        "十倍股",
                        "共性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：增长依赖代理产品 上半年净利润约15亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "代理产品",
                        "净利润"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}